| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical Benefits of Epoetin Alfa Therapy in Patients with Lung Cancer
|
Crawford, Jeffrey
|
|
2002
|
3 |
Supplement 2 |
p. 180-190
11 p.
|
artikel
|
| 2 |
Induction and Concurrent Paclitaxel/Carboplatin Every 3 Weeks with Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: An Interim Report
|
Movsas, Benjamin
|
|
2001
|
3 |
Supplement 2 |
p. 125-132
8 p.
|
artikel
|
| 3 |
Intraluminal Brachytherapy for Malignant Endobronchial Tumors: An Update on Low-Dose Rate Versus High-Dose Rate Radiation Therapy
|
Lo, Theodore C.M.
|
|
2001
|
3 |
Supplement 2 |
p. 65-68
4 p.
|
artikel
|
| 4 |
Jettisoning the COXswain: Inhibitors of Eicosanoids and Lung Cancer
|
Gazdar, Adi F.
|
|
2002
|
3 |
Supplement 2 |
p. 278-
1 p.
|
artikel
|
| 5 |
Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)
|
Lyss, Alan P.
|
|
2002
|
3 |
Supplement 2 |
p. 205-210
6 p.
|
artikel
|
| 6 |
Phase II Study of Sequential Treatment of Advanced Non–Small-Cell Lung Cancer: Three Cycles of High-Dose Epirubicin Plus Cisplatin Followed by Weekly Vinorelbine
|
Guaraldi, Monica
|
|
2001
|
3 |
Supplement 2 |
p. 43-46
4 p.
|
artikel
|
| 7 |
Phase I Study of Dose-Dense Alternating Doublets in Advanced Non—Small-Cell Lung Cancer
|
Vokes, Everett E.
|
|
2002
|
3 |
Supplement 2 |
p. 265-270
6 p.
|
artikel
|
| 8 |
Phase I Study of the BLP25 (MUC1 Peptide) Liposomal Vaccine for Active Specific Immunotherapy in Stage IIIB/IV Non–Small-Cell Lung Cancer
|
Palmer, Martin
|
|
2001
|
3 |
Supplement 2 |
p. 49-57
9 p.
|
artikel
|
| 9 |
Photodynamic Therapy for Patients with Advanced Non–Small-Cell Carcinoma of the Lung
|
Jones, Blanding U.
|
|
2001
|
3 |
Supplement 2 |
p. 37-41
5 p.
|
artikel
|
| 10 |
Second-Line Chemotherapy for Small-Cell Lung Cancer: A Review
|
Schultheis, Christian P.
|
|
2001
|
3 |
Supplement 2 |
p. 118-124
7 p.
|
artikel
|
| 11 |
Temozolomide in Non—Small-Cell Lung Cancer: Preliminary Results of a Phase II Trial in Previously Treated Patients
|
Adonizio, Christian S.
|
|
2002
|
3 |
Supplement 2 |
p. 254-258
5 p.
|
artikel
|
| 12 |
The Future of Cyclooxygenase-2 Inhibitors and Other Inhibitors of the Eicosanoid Signal Pathway in the Prevention and Therapy of Lung Cancer
|
Bunn Jr., Paul A.
|
|
2002
|
3 |
Supplement 2 |
p. 271-277
7 p.
|
artikel
|
| 13 |
The Role of Semaphorins in Lung Cancer
|
Roche, Joélle
|
|
2001
|
3 |
Supplement 2 |
p. 145-150
6 p.
|
artikel
|
| 14 |
Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Early-Stage Non–Small-Cell Lung Cancer
|
Rosenzweig, Kenneth E.
|
|
2001
|
3 |
Supplement 2 |
p. 141-144
4 p.
|
artikel
|
| 15 |
Update on Results of Multifield Conformal Radiation Therapy of Non—Small-Cell Lung Cancer Using Multileaf Collimated Beams
|
Bhatnagar, Ajay
|
|
2002
|
3 |
Supplement 2 |
p. 259-264
6 p.
|
artikel
|
Tijdschrift beschrijving